Stay updated on Acalabrutinib in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Acalabrutinib in Ovarian Cancer Clinical Trial page.

Latest updates to the Acalabrutinib in Ovarian Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe study record for the Phase 2 ovarian cancer trial is displayed, including its eligibility criteria, treatment arms, outcome measures, locations, and record documents. It indicates the study is completed and is no longer recruiting participants.SummaryDifference42%

- Check16 days agoChange DetectedThe footer revision changes from v3.7.2 to v3.8.0, while the study page remains unavailable with a 403 error.SummaryDifference0.2%

- Check23 days agoChange DetectedA banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check30 days agoChange DetectedThe footer’s site revision label changed from v3.7.1 to v3.7.2 while the page continued to display a 403 error.SummaryDifference0.2%

- Check37 days agoChange DetectedThe site footer revision number changes from v3.7.0 to v3.7.1 while the study page continues to display a 403 error.SummaryDifference0.2%

- Check57 days agoChange DetectedThe page now shows a 403 error, replacing the usual study record content with a generic header and navigation. Consequently, readers cannot access the trial information or submission history on this page.SummaryDifference17%

Stay in the know with updates to Acalabrutinib in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Acalabrutinib in Ovarian Cancer Clinical Trial page.